Sanofi Pasteur Nets Flu Vaccine Via Acambis Purchase
This article was originally published in The Pink Sheet Daily
Executive Summary
Early C. difficile program comes along with $550 million deal.
You may also be interested in...
Merck Re-enters Flu Vaccine Business: Seals Six-year Afluria Marketing Deal With Australia's CSL
Merck took its time coming back into the flu vaccine field, but the expansion of world suppliers of vaccines brought a very well-suited partner to its doorstep
Merck Re-enters Flu Vaccine Business: Seals Six-year Afluria Marketing Deal With CSL
Deal with long-time Australian partner could add up to $100 million to Merck's business in the 2010/2011 flu season, analyst says.
Merck Re-enters Flu Vaccine Business: Seals Six-year Afluria Marketing Deal With CSL
Deal with long-time Australian partner could add up to $100 million to Merck's business in the 2010/2011 flu season, analyst says.